Safety and efficacy study on etanercept in patients with plaque psoriasis.

作者:

DOI: 10.1111/J.1365-2133.2005.06306.X

关键词:

摘要:

参考文章(8)
J F Eliaou, T Haim, G Hayem, J Sany, O Meyer, M F Kahn, A Elias, K Benali, P Nicaise, P Chazerain, B Combe, Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis The Journal of Rheumatology. ,vol. 26, pp. 7- 13 ,(1999)
Eric M Ruderman, Evaluation and management of psoriatic arthritis: the role of biologic therapy. Journal of The American Academy of Dermatology. ,vol. 49, pp. 125- 132 ,(2003) , 10.1016/S0190-9622(03)01145-9
Craig L. Leonardi, Jerold L. Powers, Robert T. Matheson, Bernard S. Goffe, Ralph Zitnik, Andrea Wang, Alice B. Gottlieb, Etanercept as Monotherapy in Patients with Psoriasis New England Journal of Medicine. ,vol. 349, pp. 2014- 2022 ,(2003) , 10.1056/NEJMOA030409
Ben Goffe, Jennifer Clay Cather, Etanercept: An overview Journal of The American Academy of Dermatology. ,vol. 49, pp. 105- 111 ,(2003) , 10.1016/MJD.2003.554
Gerald Krueger, Kristina Callis, Potential of Tumor Necrosis Factor Inhibitors in Psoriasis and Psoriatic Arthritis Archives of Dermatology. ,vol. 140, pp. 218- 225 ,(2004) , 10.1001/ARCHDERM.140.2.218
Alice B. Gottlieb, A Randomized Trial of Etanercept as Monotherapy for Psoriasis Archives of Dermatology. ,vol. 139, pp. 1627- 1632 ,(2003) , 10.1001/ARCHDERM.139.12.1627